Наши публикации

At least one-third of patients with cancer have pain at the time of their diagnosis. Nearly 75% of the patients experience moderate-severe pain in the advanced and terminal stages of their disease. Unfortunately, 10-15% of patients with cancer-related pain do not achieve acceptable levels of pain relief with opiates alone or in combination with conventional adjuvant analgesics.

Patients with failed back syndrome continue to experience low back pain despite conventional treatments and minimally invasive procedures including spinal cord stimulation. Control of axial low back pain is difficult to achieve during the trial placement of spinal cord stimulation or to maintain after permanent placement.

It has been estimated that 15% to 40% of chronic cancer pain has a neuropathic component, and this type of pain often responds poorly to opioids. In an attempt to provide increased pain relief for patients with intractable cancer pain, unconventional agents and interventional management approaches have received considerable attention. Spinal cord stimulation (SCS) has been used with increased frequency for the treatment of intractable cancer pain.

Background, Objectives, and Methods. Afew recent reports suggested that spinal cord stimulation (SCS) effectively suppresses chronic abdominal pain. However, there is no consensus on patient selection or technical aspects of SCS for such pain. That is why we conducted national survey and collected 76 case reports. There were six incompletely filled reports, so we analyzed 70 cases.

Trigeminal Neuralgia (Tic Douloureux) is the most common of all neuralgias, rarely occurs before the age 35 with incidence slightly greater in women than men. Traditional treatment options for trigeminal neuralgia include anticonvulsants, antidepressants, non-steroidal anti-inflammatory medications, and opioids.

Laparoscopic ventral hernia repair was introduced in 1993 and benefits of this technique are uncertain in comparison to open repair. Up to 9.1 % of patients who undergo this procedure experience chronic abdominal pain. The visceral component of pain was identified as main source of pain compared with incisional component.

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is characterized by craniofacial, somatic, motor and intellectual development conditions, skin, gastrointestinal system, neoplasms, skeletal system and other abnormalities are experienced in different degrees. This case reports on a 22-year-old female with a predominant skeletal abnormality — gigantism of the feet causing intractable bilateral combined joint and neurologic foot pain.

Spinal cord stimulation (SCS) has been used in treating different pain conditions but may be challenging for predominant back pain. Control for axial back pain is difficult to achieve during the trial or maintain after placement of spinal cord stimulation. SCS was effectively used to treat intractable thoracic spine pain.

Intrathecal pumps (ITP) have become a valuable tool in managing intractable non-cancer pain. Intrathecal therapy have proven successful at improving pain patients with severity and decreased oral opioid consumption. Two years after ITP pump placement patients low back and lower extremity pain was no longer adequately covered with the ITP, despite rotation of opioid, and addition of Bupivacaine.

Atypical facial pain (ATFP) represents a wide group of facial pain problems with common symptoms but a variety of different causes. These include low-grade infectious and inflammatory process, dental or physical trauma, malignant neoplasms involving the base of skull and traumatizing branches of the trigeminal nerve. Even benign tumors of the trigeminal nerve or meninges.